The Most Effective Way for Democrats to Fight Trump’s Agenda Isn’t Where You Think It Is

The end of the incumbency rule, says Tierney, could make it more difficult for attorneys general to collaborate on litigation that affects many states, red and blue, including against pharmaceutical companies. ‘Now that AGs can run against other AGs, I imagine it’s pretty difficult for them to have confidential discussions across party lines, and that’s a problem,’ he says.